In the matter of Oventus Medical Limited (Administrators Appointed)

In the matter of Oventus Medical Limited, the court considered an application by the administrators for an extension of the convening period for meetings of creditors. The primary company in question, OML, sought to recapitalise by issuing new equity to existing shareholders, potentially allowing the company to pay off all existing creditors and maintain shareholder interests. The application was made to the Federal Court, with Messrs McCann and Killer appointed as joint administrators of the companies involved, which include OML, OCRM, and others. The first meeting of creditors was convened on 24 June 2022, and the administrators argued that the extension was necessary to enable the recapitalisation process, which they believed had a reasonable chance of success.

The legal issues before the court involved determining whether the extension of the convening period was warranted under the Corporations Act 2001. The administrators argued that the extension was necessary to allow for the recapitalisation of the company, which they believed would lead to full repayment of creditors and retention of shareholder interests. The court needed to assess whether the proposed extension was in the best interest of the creditors and if there were reasonable grounds for believing that the recapitalisation would be successful. Additionally, the court had to consider whether the extension would prejudice any party or the administration process.

The court granted the application, finding that the extension was necessary to facilitate the recapitalisation process. The administrators had presented evidence that the company's value was largely derived from its intellectual property, patents, trademarks, and the expertise of its employees. The court was persuaded by the likelihood that the recapitalisation would allow all creditors to be paid in full and that shareholders could retain their interests. The court also noted the unique nature of the company's business, which was still in the development stage of commercialising its product. The order extended the convening period to 12 January 2023 and mandated that creditors be informed of the decision. The court also made provisions to prevent disclosure of certain sensitive information until the conclusion of the administration.

The final orders included extending the convening period, allowing meetings of creditors to be held during or shortly after the extended period, and requiring the administrators to notify creditors of the orders. Additionally, the court restricted the disclosure of specific information from the affidavit until the conclusion of the administration. The administrators' costs were to be paid out of the companies' property.